GLA
GRTX

Good Life Advisors’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Good Life Advisors’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-31,250
Closed -$4.38K – 492
2024
Q1 		$4.38K Hold
31,250
– – ﹤0.01% 461
2023
Q4 		$4.54K Hold
31,250
– – ﹤0.01% 436
2023
Q3 		$5.47K Buy
31,250
+20,000
+178% +$24.9K ﹤0.01% 414
2023
Q2 		$35.1K Buy
+11,250
New +$33.5K ﹤0.01% 410

Other funds holding GRTX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Good Life Advisors's GRTX Position: Q2 2024 in Review

Good Life Advisors sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 31,250 shares — an estimated $4.38K sold.

Good Life Advisors first reported a position in GRTX in Q2 2023 and held it in 4 quarters. The position peaked at $35.1K in Q2 2023. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

  • Good Life Advisors reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Good Life Advisors sold 31,250 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $4.38K.
  • Good Life Advisors first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Good Life Advisors's Galera Therapeutics, Inc. Common Stock position peaked at $35.1K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Good Life Advisors's 13F filing for Q2 2024, filed 18 Jul 2024.